EARLY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY BIOMARKERS TO CONFIRM FELLOW EYE CHANGES IN ASYMMETRIC TYPE-2 MACULAR TELANGIECTASIA: A Case-Control Study (India Macular Telangiectasia Report 1).
Journal
Retina (Philadelphia, Pa.)
ISSN: 1539-2864
Titre abrégé: Retina
Pays: United States
ID NLM: 8309919
Informations de publication
Date de publication:
01 Mar 2021
01 Mar 2021
Historique:
pubmed:
18
8
2020
medline:
17
11
2021
entrez:
18
8
2020
Statut:
ppublish
Résumé
To evaluate the earliest spectral-domain optical coherence tomography markers in fellow eyes of asymmetric Type-2 macular telangiectasia (MacTel). A multicentered case-control study of spectral-domain optical coherence tomography images captured on Spectralis Heidelberg Engineering, Germany, comparing features of fellow eyes of patients with asymmetric clinical presentation of MacTel with 50 age-matched control subjects. Of 649 patients, 28 (4.3%) with MacTel presented with asymmetric features. The mean age of the MacTel patients was 63.5 (12.4) years with female predilection (4:1). Mean best-corrected visual acuity of the unaffected eye was 0.2 logarithm of the minimum angle of resolution (20/32 Snellen equivalent). The mean central subfoveal thickness in the unaffected MacTel eyes was 194 (SD, 38) µm, and the temporal retinal thickness was 204 (SD, 43) µm. These parameters were significantly thinner than those of control subjects in whom mean central subfoveal thickness was 273 (SD, 26) µm (P = 0.001). Presence of hyperreflective outer retinal dots was found in 92.8% of the unaffected MacTel eyes. These hyperreflective dots were scattered, punctate, nonconfluent, and confined to the outer retinal layers of foveal and parafoveal region. Although these cases presented with advanced presentation of MacTel features in only one eye, temporal retinal thinning and presence of hyperreflective outer retinal dots in the fellow eye can be considered as the earliest signs of MacTel.
Identifiants
pubmed: 32804830
pii: 00006982-202103000-00004
doi: 10.1097/IAE.0000000000002954
doi:
Types de publication
Comparative Study
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
471-479Subventions
Organisme : Medical Research Council
ID : MR/P027881/1
Pays : United Kingdom
Références
Powner M, Gillies MC, Zhu M, et al. Loss of Müller's cells and photoreceptors in macular telangiectasia type 2. Ophthalmology 2013;120:2344–2352.
Jaisankar D, Raman R, Gondhale H, et al. Visual function correlates of foveal slope changes on optical coherence tomography in macular telangiectasia type 2. Retina 2017;37:2248–2253.
Zarei M, Mazloumi M, Karkhaneh R, Roohipoor R. Idiopathic macular telangiectasia type 2: a six-year study with multimodal imaging of a presumed unilateral case. J Curr Ophthalmol 2018;30:368–373.
Charbel Issa P, Heeren TF, Kupitz EH, et al. Very early disease manifestations of macular telangiectasia type 2. Retina 2016;36:524–534.
Chung MM, Song H, Chew EY, et al. Adaptive optics scanning laser ophthalmoscopy demonstrates reduced foveal cone density in early idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci 2012;53:1753.
Charbel Issa P, Finger RP, Helb HM, et al. A new diagnostic approach in patients with type 2 macular telangiectasia: confocal reflectance imaging. Acta Ophthalmol 2008;86:464–465.
Sauer L, Gensure RH, Hammer M, Bernstein PS. Fluorescence lifetime imaging ophthalmoscopy: a novel way to assess macular telangiectasia type 2. Ophthalmol Retina 2018;2:587–598.
Green-Gomez M, Bernstein PS, Curcio CA, et al. Standardizing the assessment of macular pigment using a dual-wavelength autofluorescence technique. Translational Vis Sci Technol 2019;8:41.
Maruko I, Iida T, Sekiryu T, Fujiwara T. Early morphological changes and functional abnormalities in group 2A idiopathic juxtafoveolar retinal telangiectasis using spectral domain optical coherence tomography and microperimetry. Br J Ophthalmol 2008;92:1488–1491.
Gaudric A, Ducos de Lahitte G, Cohen SY, et al. Optical coherence tomography in group 2A idiopathic juxtafoveolar retinal telangiectasis. Arch Ophthalmol 2006;124:1410–1419.
Gantner ML, Eade K, Wallace M, et al. Serine and lipid metabolism in macular disease and peripheral neuropathy. N Engl J Med 2019;381:1422–1433.
Wang Q, Tuten WS, Lujan BJ, et al. Adaptive optics microperimetry and OCT images show preserved function and recovery of cone visibility in macular telangiectasia type 2 retinal lesions. Invest Ophthalmol Vis Sci 2015;56:778–786.
Schmitz-Valckenberg S, Fan K, Nugent A, et al. Correlation of functional impairment and morphological alterations in patients with group 2A idiopathic juxtafoveal retinal telangiectasia. Arch Ophthalmol 2008;126:330–335.
Gillies MC, Zhu M, Chew E, et al. Familial asymptomatic macular telangiectasia type 2. Ophthalmology 2009;116:2422–2429.
Wong WT, Forooghian F, Majumdar Z, et al. Fundus autofluorescence in type 2 idiopathic macular telangiectasia: correlation with optical coherence tomography and microperimetry. Am J Ophthalmol 2009;148:573–583.
Yung M, Klufas MA, Sarraf D. Clinical applications of fundus autofluorescence in retinal disease. Int J Retina Vitreous 2016;2:12.
Baumüller S, Charbel Issa P, Scholl HP, et al. Outer retinal hyperreflective spots on spectral-domain optical coherence tomography in macular telangiectasia type 2. Ophthalmology 2010;117:2162–2168.
Sallo FB, Leung I, Chung M, et al.; MacTel Study Group. Retinal crystals in type 2 idiopathic macular telangiectasia. Ophthalmology 2011;118:2461–2467.
Powner MB, Gillies MC, Tretiach MP, et al. Perifoveal Müller cell depletion in a case of macular telangiectasia type 2. Ophthalmology 2010;117:2407–2416.
Bringmann A, Pannicke T, Biedermann B, et al. Role of retinal glial cells in neurotransmitter uptake and metabolism. Neurochem Int 2009;54:143–160.
Bringmann A, Iandiev I, Pannicke T, et al. Cellular signaling and factors involved in Müller cell gliosis: neuroprotective and detrimental effects. Prog Retin Eye Res 2009;28:423–451.
Jablonski MM, Iannaccone A. Targeted disruption of Muller cell metabolism induces photoreceptor dysmorphogenesis. Glia 2000;32:192–204.
Issa PC, Helb HM, Holz FG; Scholl HP MacTel Study Group. Correlation of macular function with retinal thickness in nonproliferative type 2 idiopathic macular telangiectasia. Am J Ophthalmol 2008;145:169–175.
Barthelmes D, Sutter FK, Gillies MC. Differential optical densities of intraretinal spaces. Invest Ophthalmol Vis Sci 2008;49:3529–3534.
Gass JD, Blodi BA. Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study. Ophthalmology 1993;100:1536–1546.
Charbel Issa P, Holz FG, Scholl HP. Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia. Ophthalmology 2007;114:1736–1742.
Bolz M, Schmidt-Erfurth U, Deak G, et al. Optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema. Ophthalmology 2009;116:914–920.
Uji A, Murakami T, Nishijima K, et al. Association between hyperreflective foci in the outer retina, status of photoreceptor layer, and visual acuity in diabetic macular edema. Am J Ophthalmol 2012;153:710–717.
Vujosevic S, Bini S, Torresin T, et al. Hyperreflective retinal spots in normal and diabetic eyes: B-scan and en face spectral domain optical coherence tomography evaluation. Retina 2017;37:1092–1103.